KALV PEER ANALYSIS

Kalvista Pharmaceuticals Inc — metric-by-metric comparison with peers and the industry median

KALVKalvista Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

KALVIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	KALV	MSB	TLX	CSL	RTALB	Ind. Median
P/E	—	—	—	30.02	4.89●	17.81
P/B	-503.31●	—	6.56	2.24	0.61	3.49
EV/EBITDA	—	—	123.31	10.37●	74.61	14.92
P/S	9.54	31.91	3.34	2.67●	6.67	10.89

Financial Health
Metric	KALV	MSB	TLX	CSL	RTALB	Ind. Median
Current Ratio	5.58●	—	1.43	2.57	1.21	5.90
Debt/Equity	-10,483.5%●	—	112.3%	67.4%	1.2%	10.9%
NetDebt/EBITDA	0.21●	—	13.13	2.22	0.90	1.15

Profitability
Metric	KALV	MSB	TLX	CSL	RTALB	Ind. Median
Net Margin	-78.6%	-115.3%	-0.9%	9.2%	136.3%●	-125.7%
ROE	-242.6%	-11.3%	-1.8%	7.7%	15.1%●	-47.5%
ROA	-38.4%	-8.6%	-0.7%	3.8%	13.1%●	-35.8%
EBITDA Margin	-52.4%	-76.6%	3.0%	32.8%●	9.0%	-105.8%

Growth + Dividend
Metric	KALV	MSB	TLX	CSL	RTALB	Ind. Median
Rev. Growth	—	410.4%●	56.3%	4.8%	24.0%	5.1%
NI Growth	—	—	—	-39.4%	134.0%●	12.1%
Div. Yield	—	0.0%	—	2.5%●	0.0%	0.2%
Payout	—	0.0%	—	103.1%	0.0%	0.0%

Valuation
Metric	KALV	MNKD	OLMA	ARDX	VIR	WVE	Ind. Median
P/E	—	—	—	—	—	—	17.81
P/B	-503.31●	-22.24	2.73	8.83	1.82	2.47	3.49
EV/EBITDA	—	58.77	—	—	—	—	14.92
P/S	9.54	3.65	—	3.07●	22.54	17.62	10.89

Financial Health
Metric	KALV	MNKD	OLMA	ARDX	VIR	WVE	Ind. Median
Current Ratio	5.58	1.87	10.88	3.49	7.11	11.26●	5.90
Debt/Equity	-10,483.5%●	-737.7%	0.2%	140.1%	11.8%	3.1%	10.9%
NetDebt/EBITDA	0.21●	10.99	2.73	1.17	0.86	3.03	1.15

Profitability
Metric	KALV	MNKD	OLMA	ARDX	VIR	WVE	Ind. Median
Net Margin	-78.6%	-6.6%●	—	-13.6%	-676.0%	-255.7%	-125.7%
ROE	-242.6%	—	-42.9%	-39.5%●	-47.7%	-53.7%	-47.5%
ROA	-38.4%	-4.1%●	-39.4%	-12.7%	-37.9%	-42.1%	-35.8%
EBITDA Margin	-52.4%	7.6%●	—	-6.0%	-669.6%	-243.2%	-105.8%

Growth + Dividend
Metric	KALV	MNKD	OLMA	ARDX	VIR	WVE	Ind. Median
Rev. Growth	—	21.2%	-100.0%	18.2%	214.0%●	-31.6%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on KALV

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jun 12, 26. This content is for informational purposes only and is not investment advice.